Literature DB >> 1693568

Regulation of insulin-like growth factor (IGF)-binding protein synthesis by insulin and IGF-I in cultured bovine fibroblasts.

C A Conover1.   

Abstract

Specific insulin-like growth factor-binding proteins (IGFBPs) are synthesized and secreted by bovine fibroblasts in vitro. By Western ligand blotting, three molecular forms of IGFBP were identified in conditioned medium from control cultures with mol wt (Mr) of 34,000, 28,000, and 24,000. Concentrations of these three IGFBP forms increased with time in serum-free conditioned medium without benefit of hormonal supplementation. Insulin and IGF-I were potent stimuli for IGFBP production by bovine fibroblasts, whereas bovine GH, epidermal growth factor, or steroid treatment had little or no effect. Insulin and IGF-I enhanced the production of 24,000, 28,000, and 34,000 Mr IGFBPs in a dose-dependent fashion. Moreover, addition of low nanomolar concentrations of insulin or IGF-I to bovine fibroblast cultures specifically induced the secretion of a 42,000/38,000 Mr species of IGFBP, which corresponded in size to the IGF-binding subunit of the principal 150,000 Mr IGFBP complex in serum. After stimulation with insulin or IGF-I, bovine fibroblasts (3 X 10(5) cells) secreted approximately 30 ng/24 h 42,000/38,000 Mr IGFBP. Subunits of 42,000/38,000 Mr in bovine fibroblast-conditioned medium did not form macromolecular complexes in either the absence or presence of bovine GH.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693568     DOI: 10.1210/endo-126-6-3139

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  Loss of the pregnancy-induced rise in cortisol concentrations in the ewe impairs the fetal insulin-like growth factor axis.

Authors:  Ellen C Jensen; Laura Bennet; Charles Wood; Mark Vickers; Bernhard Breier; Alistair J Gunn; Maureen Keller-Wood
Journal:  Reprod Fertil Dev       Date:  2011       Impact factor: 2.311

2.  Serum levels of insulin-like growth factors (IGF-I and IGF-II) and their binding protein (IGFBP-3) are not elevated in pancreatic cancer.

Authors:  J D Evans; M C Eggo; I A Donovan; S R Bramhall; J P Neoptolemos
Journal:  Int J Pancreatol       Date:  1997-10

3.  A unique receptor-independent mechanism by which insulinlike growth factor I regulates the availability of insulinlike growth factor binding proteins in normal and transformed human fibroblasts.

Authors:  C A Conover
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

4.  Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies.

Authors:  C A Conover; M C Kiefer; J Zapf
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

5.  The role of insulin-like growth factor-1 (IGF-1) in follicular thyroid cancer cell line CGTH W-1.

Authors:  J D Lin; Y S Ho; H Y Chang; H F Weng
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-12       Impact factor: 2.416

6.  Insulin-like growth factor binding protein-3 protease activity in the urine of children with chronic renal failure.

Authors:  D Y Lee; P Cohen; A M Krensky; R G Rosenfeld; P D Yorgin
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

7.  Insulin-like growth factor (IGF)-I and -II and IGFBP secretion by ovine satellite cell strains grown alone or in coculture with 3T3-L1 preadipocytes.

Authors:  K L Hossner; R Yemm; J Vierck; M V Dodson
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997 Nov-Dec       Impact factor: 2.723

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.